Physician profile
Syed I Moin
NPI 1447335351
$2,130.42
in general payments reported to CMS, 2019-2025
23 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,620 · 2020: $240 · 2023: $77.12 · 2024: $68.54 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $356.82 | 2019-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.16 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $189.23 | 2019-2020 | |
| Glaxosmithkline, LLC. | $187.93 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $159.47 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $143.91 | 2019-2020 | |
| Pfizer INC. | $108.73 | 2019 | |
| Lilly USA, LLC | $100.35 | 2019-2020 | |
| Amarin Pharma, INC. | $93.56 | 2019-2020 | |
| Indivior INC. | $84.06 | 2019-2024 | Sublocade |
| Merck Sharp & Dohme LLC | $79.12 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.59 | 2019 | |
| Orexo US, INC. | $58.67 | 2023-2024 | Zubsolv |
| Smith+Nephew, INC. | $56.42 | 2019 | |
| Shionogi INC | $48.12 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $42.37 | 2019 | |
| Astellas Pharma US INC | $42.04 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $24.11 | 2019 | |
| Avanir Pharmaceuticals, INC. | $17.79 | 2019 | |
| Melinta Therapeutics, LLC | $15.11 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.13 | 2019 | |
| Electromed, INC. | $13.40 | 2019 | |
| Allergan, INC. | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Moin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.